|
Mar 15
|
Adma Biologics (ADMA) Stock Moves -0.5%: What You Should Know
|
|
Mar 15
|
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
|
|
Mar 15
|
Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss
|
|
Mar 13
|
Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study
|
|
Mar 13
|
Pfizer's (PFE) Adcetris Meets Survival Goal in Lymphoma Study
|
|
Mar 11
|
Amylyx's (AMLX) ALS Drug Fails Pivotal Study, Stock Down 82%
|
|
Mar 11
|
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
|
|
Mar 8
|
MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag
|
|
Mar 7
|
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
|
|
Mar 7
|
Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia
|
|
Mar 6
|
Novo Nordisk (NVO) Down Despite Kidney Outcomes Study Success
|
|
Mar 5
|
Finding Cheap Stocks Under $10 to Buy in March
|
|
Mar 5
|
FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
|
|
Mar 5
|
Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should Know
|
|
Mar 5
|
Zacks.com featured highlights Griffon, HNI, ADMA Biologics and First Bank
|
|
Mar 5
|
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
|
|
Mar 4
|
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Mar 4
|
4 Stocks With Increasing Cash Flows to Enrich Your Portfolio
|
|
Feb 28
|
ADMA Biologics Inc Reports Robust Revenue Growth and Positive Adjusted Net Income for FY 2023
|
|
Feb 28
|
ADMA Biologics Announces CFO Transition
|